-+ 0.00%
-+ 0.00%
-+ 0.00%

ARS PHARMACEUTICALS INC: TOTAL 2026 CASH-BASED OPERATING EXPENSES, EXCLUDING COGS, LOWERED TO $248 MLN

Reuters·06/24/2026 20:05:00

Please log in to view news